The Precision Peptide Genetic Test ($99 add-on) identifies genetic variants in GLP1R, GIPR, MC4R, and FTO that influence your peptide pathway sensitivity and GLP-1 response, helping personalize your treatment dose and side effect profile
J Clin Epidemiol 64:11871197 Fukami K, Yamagishi S-I, Sakai K, Kaida Y, Adachi T, Ando R, Okuda S (2013) Potential inhibitory effects of L-carnitine supplementation on tissue advanced glycation end products in patients with hemodialysis
PMC 5683008
In clinical trials of ZEPBOUND, cholelithiasis was reported in 1.1% of ZEPBOUND-treated patients and 1% of placebo-treated patients, cholecystitis was reported in 0.7% of ZEPBOUND-treated patients and 0.2% of placebo-treated patients, and cholecystectomy was reported in 0.2% of ZEPBOUND-treated patients and no placebo-treated patients
Only 7% of adults meet the recommended intake every day
During this visit, well perform a thorough evaluation of your medical history, lifestyle, and weight loss goals